nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—stomach cancer	0.333	0.515	CiPCiCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—stomach cancer	0.313	0.485	CiPCiCtD
Nelarabine—Cladribine—Floxuridine—stomach cancer	0.11	0.512	CrCrCtD
Nelarabine—Decitabine—Floxuridine—stomach cancer	0.105	0.488	CrCrCtD
Nelarabine—DGUOK—hematopoietic system—stomach cancer	0.00182	0.0884	CbGeAlD
Nelarabine—DGUOK—smooth muscle tissue—stomach cancer	0.00161	0.0778	CbGeAlD
Nelarabine—DGUOK—lymphoid tissue—stomach cancer	0.00128	0.0622	CbGeAlD
Nelarabine—DGUOK—digestive system—stomach cancer	0.00127	0.0615	CbGeAlD
Nelarabine—DGUOK—bone marrow—stomach cancer	0.00117	0.0566	CbGeAlD
Nelarabine—POLA1—hematopoietic system—stomach cancer	0.00112	0.0545	CbGeAlD
Nelarabine—DGUOK—endocrine gland—stomach cancer	0.00105	0.0508	CbGeAlD
Nelarabine—ADA—hematopoietic system—stomach cancer	0.00104	0.0506	CbGeAlD
Nelarabine—DGUOK—liver—stomach cancer	0.000944	0.0458	CbGeAlD
Nelarabine—DCK—Topotecan—Irinotecan—stomach cancer	0.000906	0.688	CbGdCrCtD
Nelarabine—ADA—lymphoid tissue—stomach cancer	0.000734	0.0356	CbGeAlD
Nelarabine—ADA—digestive system—stomach cancer	0.000725	0.0352	CbGeAlD
Nelarabine—DGUOK—lymph node—stomach cancer	0.000724	0.0351	CbGeAlD
Nelarabine—POLA1—bone marrow—stomach cancer	0.000721	0.0349	CbGeAlD
Nelarabine—DCK—hematopoietic system—stomach cancer	0.000693	0.0336	CbGeAlD
Nelarabine—ADA—bone marrow—stomach cancer	0.000669	0.0324	CbGeAlD
Nelarabine—ADA—endocrine gland—stomach cancer	0.000599	0.0291	CbGeAlD
Nelarabine—POLA1—liver—stomach cancer	0.000583	0.0282	CbGeAlD
Nelarabine—DCK—pancreas—stomach cancer	0.000565	0.0274	CbGeAlD
Nelarabine—DCK—lymphoid tissue—stomach cancer	0.000488	0.0237	CbGeAlD
Nelarabine—DCK—digestive system—stomach cancer	0.000482	0.0234	CbGeAlD
Nelarabine—Adenosine monophosphate—FBP1—stomach cancer	0.000457	0.191	CrCbGaD
Nelarabine—Adenosine monophosphate—PRKAB1—stomach cancer	0.000457	0.191	CrCbGaD
Nelarabine—POLA1—lymph node—stomach cancer	0.000447	0.0217	CbGeAlD
Nelarabine—DCK—bone marrow—stomach cancer	0.000444	0.0215	CbGeAlD
Nelarabine—ADA—lymph node—stomach cancer	0.000414	0.0201	CbGeAlD
Nelarabine—DCK—endocrine gland—stomach cancer	0.000398	0.0193	CbGeAlD
Nelarabine—Cytarabine—NT5E—stomach cancer	0.000384	0.16	CrCbGaD
Nelarabine—DCK—liver—stomach cancer	0.000359	0.0174	CbGeAlD
Nelarabine—Azacitidine—DNMT1—stomach cancer	0.000309	0.129	CrCbGaD
Nelarabine—Decitabine—DNMT1—stomach cancer	0.000301	0.126	CrCbGaD
Nelarabine—DCK—lymph node—stomach cancer	0.000275	0.0133	CbGeAlD
Nelarabine—Adenosine monophosphate—PRKAA1—stomach cancer	0.000263	0.109	CrCbGaD
Nelarabine—Adenosine triphosphate—PRKAA1—stomach cancer	0.000228	0.0949	CrCbGaD
Nelarabine—DCK—Doxorubicin—Epirubicin—stomach cancer	0.000213	0.162	CbGdCrCtD
Nelarabine—DCK—Epirubicin—Doxorubicin—stomach cancer	0.000197	0.15	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—PDHA1—stomach cancer	7.74e-05	0.00144	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ECHS1—stomach cancer	7.74e-05	0.00144	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—SERPINE1—stomach cancer	7.59e-05	0.00141	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	7.44e-05	0.00138	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TYMP—stomach cancer	7.28e-05	0.00135	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FADS1—stomach cancer	7.28e-05	0.00135	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	7.26e-05	0.00135	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—PLAU—stomach cancer	7.06e-05	0.00131	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SREBF2—stomach cancer	6.82e-05	0.00127	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—PPP2R1A—stomach cancer	6.81e-05	0.00126	CbGpPWpGaD
Nelarabine—POLA1—S Phase—APEX1—stomach cancer	6.8e-05	0.00126	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN2A—stomach cancer	6.75e-05	0.00125	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—RORA—stomach cancer	6.74e-05	0.00125	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2D—stomach cancer	6.41e-05	0.00119	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—stomach cancer	6.31e-05	0.00117	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALDOB—stomach cancer	6.31e-05	0.00117	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	6.31e-05	0.00117	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—TYMS—stomach cancer	6.21e-05	0.00115	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN1B—stomach cancer	5.98e-05	0.00111	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACAD8—stomach cancer	5.9e-05	0.0011	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALOX5—stomach cancer	5.87e-05	0.00109	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	5.8e-05	0.00108	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—CDKN1A—stomach cancer	5.8e-05	0.00108	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—DPYD—stomach cancer	5.77e-05	0.00107	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PPP2R1A—stomach cancer	5.74e-05	0.00107	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2D—stomach cancer	5.74e-05	0.00106	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CCND1—stomach cancer	5.7e-05	0.00106	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	5.66e-05	0.00105	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TYMS—stomach cancer	5.64e-05	0.00105	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN1A—stomach cancer	5.52e-05	0.00102	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—SERPINE1—stomach cancer	5.46e-05	0.00101	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACAD8—stomach cancer	5.45e-05	0.00101	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—AURKB—stomach cancer	5.39e-05	0.001	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	5.38e-05	0.001	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	5.36e-05	0.000996	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GMPR2—stomach cancer	5.26e-05	0.000977	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—TYMS—stomach cancer	5.24e-05	0.000972	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	5.12e-05	0.00095	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTT1—stomach cancer	5.1e-05	0.000948	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—stomach cancer	5.1e-05	0.000947	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2A6—stomach cancer	5.05e-05	0.000937	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	4.95e-05	0.000919	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	4.92e-05	0.000913	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKR1C3—stomach cancer	4.91e-05	0.000911	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GMPR2—stomach cancer	4.86e-05	0.000902	CbGpPWpGaD
Nelarabine—Muscular weakness—Doxorubicin—stomach cancer	4.83e-05	0.000787	CcSEcCtD
Nelarabine—Vision blurred—Capecitabine—stomach cancer	4.82e-05	0.000785	CcSEcCtD
Nelarabine—ADA—Metabolism—IDH3B—stomach cancer	4.81e-05	0.000894	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SUCLG1—stomach cancer	4.81e-05	0.000894	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—stomach cancer	4.81e-05	0.000892	CbGpPWpGaD
Nelarabine—Tremor—Capecitabine—stomach cancer	4.79e-05	0.000781	CcSEcCtD
Nelarabine—Neutropenia—Epirubicin—stomach cancer	4.78e-05	0.000779	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ENO1—stomach cancer	4.78e-05	0.000888	CbGpPWpGaD
Nelarabine—Abdominal distension—Doxorubicin—stomach cancer	4.76e-05	0.000776	CcSEcCtD
Nelarabine—Stomatitis—Methotrexate—stomach cancer	4.75e-05	0.000774	CcSEcCtD
Nelarabine—Leukopenia—Docetaxel—stomach cancer	4.73e-05	0.00077	CcSEcCtD
Nelarabine—Anaemia—Capecitabine—stomach cancer	4.73e-05	0.00077	CcSEcCtD
Nelarabine—Body temperature increased—Fluorouracil—stomach cancer	4.72e-05	0.000769	CcSEcCtD
Nelarabine—Loss of consciousness—Docetaxel—stomach cancer	4.64e-05	0.000757	CcSEcCtD
Nelarabine—Hyperglycaemia—Epirubicin—stomach cancer	4.61e-05	0.000752	CcSEcCtD
Nelarabine—Cough—Docetaxel—stomach cancer	4.61e-05	0.000751	CcSEcCtD
Nelarabine—Hepatobiliary disease—Methotrexate—stomach cancer	4.61e-05	0.000751	CcSEcCtD
Nelarabine—Epistaxis—Methotrexate—stomach cancer	4.6e-05	0.000749	CcSEcCtD
Nelarabine—Pneumonia—Epirubicin—stomach cancer	4.59e-05	0.000747	CcSEcCtD
Nelarabine—Leukopenia—Capecitabine—stomach cancer	4.58e-05	0.000746	CcSEcCtD
Nelarabine—Convulsion—Docetaxel—stomach cancer	4.58e-05	0.000746	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—MYC—stomach cancer	4.58e-05	0.000849	CbGpPWpGaD
Nelarabine—Infestation—Epirubicin—stomach cancer	4.56e-05	0.000743	CcSEcCtD
Nelarabine—Infestation NOS—Epirubicin—stomach cancer	4.56e-05	0.000743	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—CDKN1B—stomach cancer	4.52e-05	0.000839	CbGpPWpGaD
Nelarabine—Myalgia—Docetaxel—stomach cancer	4.5e-05	0.000733	CcSEcCtD
Nelarabine—Chest pain—Docetaxel—stomach cancer	4.5e-05	0.000733	CcSEcCtD
Nelarabine—Arthralgia—Docetaxel—stomach cancer	4.5e-05	0.000733	CcSEcCtD
Nelarabine—Loss of consciousness—Capecitabine—stomach cancer	4.5e-05	0.000732	CcSEcCtD
Nelarabine—Asthenia—Irinotecan—stomach cancer	4.48e-05	0.000729	CcSEcCtD
Nelarabine—ADA—Metabolism—NDUFV1—stomach cancer	4.47e-05	0.000831	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NDUFS1—stomach cancer	4.47e-05	0.000831	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Epirubicin—stomach cancer	4.47e-05	0.000728	CcSEcCtD
Nelarabine—Cough—Capecitabine—stomach cancer	4.46e-05	0.000727	CcSEcCtD
Nelarabine—Stomatitis—Epirubicin—stomach cancer	4.45e-05	0.000724	CcSEcCtD
Nelarabine—DCK—Metabolism—IDH3B—stomach cancer	4.44e-05	0.000825	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SUCLG1—stomach cancer	4.44e-05	0.000825	CbGpPWpGaD
Nelarabine—Neutropenia—Doxorubicin—stomach cancer	4.43e-05	0.000721	CcSEcCtD
Nelarabine—POLA1—S Phase—CDK4—stomach cancer	4.4e-05	0.000816	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CDK4—stomach cancer	4.39e-05	0.000816	CbGpPWpGaD
Nelarabine—Myalgia—Capecitabine—stomach cancer	4.36e-05	0.000709	CcSEcCtD
Nelarabine—Chest pain—Capecitabine—stomach cancer	4.36e-05	0.000709	CcSEcCtD
Nelarabine—Arthralgia—Capecitabine—stomach cancer	4.36e-05	0.000709	CcSEcCtD
Nelarabine—Confusional state—Docetaxel—stomach cancer	4.35e-05	0.000708	CcSEcCtD
Nelarabine—Urinary tract disorder—Methotrexate—stomach cancer	4.32e-05	0.000704	CcSEcCtD
Nelarabine—Hepatobiliary disease—Epirubicin—stomach cancer	4.31e-05	0.000703	CcSEcCtD
Nelarabine—Oedema—Docetaxel—stomach cancer	4.31e-05	0.000702	CcSEcCtD
Nelarabine—Epistaxis—Epirubicin—stomach cancer	4.3e-05	0.000701	CcSEcCtD
Nelarabine—Urethral disorder—Methotrexate—stomach cancer	4.29e-05	0.000699	CcSEcCtD
Nelarabine—Infection—Docetaxel—stomach cancer	4.28e-05	0.000698	CcSEcCtD
Nelarabine—Sinusitis—Epirubicin—stomach cancer	4.28e-05	0.000697	CcSEcCtD
Nelarabine—Hyperglycaemia—Doxorubicin—stomach cancer	4.27e-05	0.000695	CcSEcCtD
Nelarabine—Diarrhoea—Irinotecan—stomach cancer	4.27e-05	0.000695	CcSEcCtD
Nelarabine—Pneumonia—Doxorubicin—stomach cancer	4.24e-05	0.000691	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CD44—stomach cancer	4.24e-05	0.000788	CbGpPWpGaD
Nelarabine—Nervous system disorder—Docetaxel—stomach cancer	4.23e-05	0.000689	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—KRAS—stomach cancer	4.23e-05	0.000785	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Docetaxel—stomach cancer	4.22e-05	0.000688	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—stomach cancer	4.22e-05	0.000687	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—stomach cancer	4.22e-05	0.000687	CcSEcCtD
Nelarabine—Confusional state—Capecitabine—stomach cancer	4.21e-05	0.000686	CcSEcCtD
Nelarabine—Oedema—Capecitabine—stomach cancer	4.18e-05	0.00068	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—CDKN1A—stomach cancer	4.17e-05	0.000774	CbGpPWpGaD
Nelarabine—Infection—Capecitabine—stomach cancer	4.15e-05	0.000676	CcSEcCtD
Nelarabine—Neuropathy peripheral—Doxorubicin—stomach cancer	4.14e-05	0.000674	CcSEcCtD
Nelarabine—DCK—Metabolism—NDUFV1—stomach cancer	4.13e-05	0.000767	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NDUFS1—stomach cancer	4.13e-05	0.000767	CbGpPWpGaD
Nelarabine—Dizziness—Irinotecan—stomach cancer	4.13e-05	0.000672	CcSEcCtD
Nelarabine—Stomatitis—Doxorubicin—stomach cancer	4.11e-05	0.00067	CcSEcCtD
Nelarabine—Anorexia—Docetaxel—stomach cancer	4.11e-05	0.00067	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	4.11e-05	0.000762	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	4.11e-05	0.000762	CbGpPWpGaD
Nelarabine—Nervous system disorder—Capecitabine—stomach cancer	4.09e-05	0.000667	CcSEcCtD
Nelarabine—Eye disorder—Methotrexate—stomach cancer	4.09e-05	0.000666	CcSEcCtD
Nelarabine—Diarrhoea—Fluorouracil—stomach cancer	4.09e-05	0.000666	CcSEcCtD
Nelarabine—Thrombocytopenia—Capecitabine—stomach cancer	4.09e-05	0.000666	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDK4—stomach cancer	4.08e-05	0.000758	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Epirubicin—stomach cancer	4.07e-05	0.000664	CcSEcCtD
Nelarabine—Cardiac disorder—Methotrexate—stomach cancer	4.06e-05	0.000661	CcSEcCtD
Nelarabine—Urinary tract disorder—Epirubicin—stomach cancer	4.04e-05	0.000659	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	4.04e-05	0.00075	CbGpPWpGaD
Nelarabine—Oedema peripheral—Epirubicin—stomach cancer	4.03e-05	0.000657	CcSEcCtD
Nelarabine—Hypotension—Docetaxel—stomach cancer	4.03e-05	0.000656	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—AURKB—stomach cancer	4.03e-05	0.000748	CbGpPWpGaD
Nelarabine—Connective tissue disorder—Epirubicin—stomach cancer	4.02e-05	0.000655	CcSEcCtD
Nelarabine—Urethral disorder—Epirubicin—stomach cancer	4.01e-05	0.000654	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PPARG—stomach cancer	3.99e-05	0.000741	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Doxorubicin—stomach cancer	3.99e-05	0.00065	CcSEcCtD
Nelarabine—ADA—Metabolism—BLVRB—stomach cancer	3.99e-05	0.00074	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PGLS—stomach cancer	3.99e-05	0.00074	CbGpPWpGaD
Nelarabine—Epistaxis—Doxorubicin—stomach cancer	3.98e-05	0.000648	CcSEcCtD
Nelarabine—Anorexia—Capecitabine—stomach cancer	3.98e-05	0.000648	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—stomach cancer	3.97e-05	0.000647	CcSEcCtD
Nelarabine—Vomiting—Irinotecan—stomach cancer	3.97e-05	0.000646	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	3.97e-05	0.000736	CbGpPWpGaD
Nelarabine—Sinusitis—Doxorubicin—stomach cancer	3.96e-05	0.000645	CcSEcCtD
Nelarabine—Dizziness—Fluorouracil—stomach cancer	3.95e-05	0.000644	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—stomach cancer	3.94e-05	0.000642	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Docetaxel—stomach cancer	3.93e-05	0.00064	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	3.93e-05	0.000729	CbGpPWpGaD
Nelarabine—Chills—Methotrexate—stomach cancer	3.93e-05	0.000639	CcSEcCtD
Nelarabine—Headache—Irinotecan—stomach cancer	3.91e-05	0.000637	CcSEcCtD
Nelarabine—Hypotension—Capecitabine—stomach cancer	3.9e-05	0.000636	CcSEcCtD
Nelarabine—Insomnia—Docetaxel—stomach cancer	3.9e-05	0.000635	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—stomach cancer	3.87e-05	0.000631	CcSEcCtD
Nelarabine—Dyspnoea—Docetaxel—stomach cancer	3.85e-05	0.000626	CcSEcCtD
Nelarabine—Somnolence—Docetaxel—stomach cancer	3.83e-05	0.000625	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—stomach cancer	3.83e-05	0.000624	CcSEcCtD
Nelarabine—Eye disorder—Epirubicin—stomach cancer	3.83e-05	0.000623	CcSEcCtD
Nelarabine—Malnutrition—Methotrexate—stomach cancer	3.81e-05	0.00062	CcSEcCtD
Nelarabine—ADA—Metabolism—PPAP2A—stomach cancer	3.8e-05	0.000706	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Capecitabine—stomach cancer	3.8e-05	0.00062	CcSEcCtD
Nelarabine—Cardiac disorder—Epirubicin—stomach cancer	3.8e-05	0.000619	CcSEcCtD
Nelarabine—Vomiting—Fluorouracil—stomach cancer	3.8e-05	0.000619	CcSEcCtD
Nelarabine—Insomnia—Capecitabine—stomach cancer	3.78e-05	0.000615	CcSEcCtD
Nelarabine—Hypoaesthesia—Doxorubicin—stomach cancer	3.77e-05	0.000614	CcSEcCtD
Nelarabine—Paraesthesia—Capecitabine—stomach cancer	3.75e-05	0.000611	CcSEcCtD
Nelarabine—Decreased appetite—Docetaxel—stomach cancer	3.75e-05	0.000611	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	3.75e-05	0.000695	CbGpPWpGaD
Nelarabine—Headache—Fluorouracil—stomach cancer	3.74e-05	0.00061	CcSEcCtD
Nelarabine—Urinary tract disorder—Doxorubicin—stomach cancer	3.74e-05	0.000609	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—stomach cancer	3.73e-05	0.000608	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—stomach cancer	3.73e-05	0.000608	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Docetaxel—stomach cancer	3.72e-05	0.000606	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—stomach cancer	3.72e-05	0.000606	CcSEcCtD
Nelarabine—Dyspnoea—Capecitabine—stomach cancer	3.72e-05	0.000606	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—stomach cancer	3.72e-05	0.000606	CcSEcCtD
Nelarabine—Angiopathy—Epirubicin—stomach cancer	3.71e-05	0.000605	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—stomach cancer	3.71e-05	0.000605	CcSEcCtD
Nelarabine—Nausea—Irinotecan—stomach cancer	3.71e-05	0.000604	CcSEcCtD
Nelarabine—Mediastinal disorder—Epirubicin—stomach cancer	3.69e-05	0.000601	CcSEcCtD
Nelarabine—Constipation—Docetaxel—stomach cancer	3.69e-05	0.000601	CcSEcCtD
Nelarabine—Pain—Docetaxel—stomach cancer	3.69e-05	0.000601	CcSEcCtD
Nelarabine—Back pain—Methotrexate—stomach cancer	3.68e-05	0.0006	CcSEcCtD
Nelarabine—DCK—Metabolism—BLVRB—stomach cancer	3.68e-05	0.000683	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PGLS—stomach cancer	3.68e-05	0.000683	CbGpPWpGaD
Nelarabine—Chills—Epirubicin—stomach cancer	3.67e-05	0.000598	CcSEcCtD
Nelarabine—Decreased appetite—Capecitabine—stomach cancer	3.63e-05	0.000591	CcSEcCtD
Nelarabine—POLA1—Synthesis of DNA—CDKN1B—stomach cancer	3.63e-05	0.000674	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	3.62e-05	0.000673	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPP2R1A—stomach cancer	3.61e-05	0.00067	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Capecitabine—stomach cancer	3.6e-05	0.000587	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—AURKB—stomach cancer	3.6e-05	0.000669	CbGpPWpGaD
Nelarabine—Fatigue—Capecitabine—stomach cancer	3.6e-05	0.000586	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—SERPINE1—stomach cancer	3.6e-05	0.000668	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—HRAS—stomach cancer	3.59e-05	0.000667	CbGpPWpGaD
Nelarabine—Vision blurred—Methotrexate—stomach cancer	3.59e-05	0.000585	CcSEcCtD
Nelarabine—Mental disorder—Epirubicin—stomach cancer	3.59e-05	0.000584	CcSEcCtD
Nelarabine—Pain—Capecitabine—stomach cancer	3.57e-05	0.000582	CcSEcCtD
Nelarabine—Constipation—Capecitabine—stomach cancer	3.57e-05	0.000582	CcSEcCtD
Nelarabine—Malnutrition—Epirubicin—stomach cancer	3.56e-05	0.000581	CcSEcCtD
Nelarabine—Feeling abnormal—Docetaxel—stomach cancer	3.55e-05	0.000579	CcSEcCtD
Nelarabine—Nausea—Fluorouracil—stomach cancer	3.55e-05	0.000578	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—stomach cancer	3.54e-05	0.000577	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GSTP1—stomach cancer	3.54e-05	0.000657	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Docetaxel—stomach cancer	3.53e-05	0.000574	CcSEcCtD
Nelarabine—Anaemia—Methotrexate—stomach cancer	3.52e-05	0.000573	CcSEcCtD
Nelarabine—Cardiac disorder—Doxorubicin—stomach cancer	3.52e-05	0.000573	CcSEcCtD
Nelarabine—DCK—Metabolism—PPAP2A—stomach cancer	3.51e-05	0.000652	CbGpPWpGaD
Nelarabine—Dysgeusia—Epirubicin—stomach cancer	3.49e-05	0.000569	CcSEcCtD
Nelarabine—DGUOK—Metabolism—HMOX1—stomach cancer	3.49e-05	0.000648	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—MYC—stomach cancer	3.46e-05	0.000642	CbGpPWpGaD
Nelarabine—Back pain—Epirubicin—stomach cancer	3.45e-05	0.000562	CcSEcCtD
Nelarabine—Feeling abnormal—Capecitabine—stomach cancer	3.44e-05	0.00056	CcSEcCtD
Nelarabine—Angiopathy—Doxorubicin—stomach cancer	3.44e-05	0.00056	CcSEcCtD
Nelarabine—Gastrointestinal pain—Capecitabine—stomach cancer	3.41e-05	0.000556	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—stomach cancer	3.41e-05	0.000556	CcSEcCtD
Nelarabine—Abdominal pain—Docetaxel—stomach cancer	3.41e-05	0.000555	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—stomach cancer	3.41e-05	0.000555	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—stomach cancer	3.41e-05	0.000555	CcSEcCtD
Nelarabine—POLA1—DNA Replication—CDKN1B—stomach cancer	3.4e-05	0.000632	CbGpPWpGaD
Nelarabine—Chills—Doxorubicin—stomach cancer	3.4e-05	0.000554	CcSEcCtD
Nelarabine—ADA—Metabolism—CKB—stomach cancer	3.39e-05	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FBP1—stomach cancer	3.39e-05	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NDUFA2—stomach cancer	3.39e-05	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA1—stomach cancer	3.39e-05	0.00063	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	3.37e-05	0.000626	CbGpPWpGaD
Nelarabine—Vision blurred—Epirubicin—stomach cancer	3.36e-05	0.000547	CcSEcCtD
Nelarabine—POLA1—Synthesis of DNA—CDKN1A—stomach cancer	3.35e-05	0.000622	CbGpPWpGaD
Nelarabine—Cough—Methotrexate—stomach cancer	3.32e-05	0.000541	CcSEcCtD
Nelarabine—Mental disorder—Doxorubicin—stomach cancer	3.32e-05	0.000541	CcSEcCtD
Nelarabine—Body temperature increased—Capecitabine—stomach cancer	3.3e-05	0.000538	CcSEcCtD
Nelarabine—Abdominal pain—Capecitabine—stomach cancer	3.3e-05	0.000538	CcSEcCtD
Nelarabine—Convulsion—Methotrexate—stomach cancer	3.3e-05	0.000538	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—stomach cancer	3.3e-05	0.000537	CcSEcCtD
Nelarabine—Anaemia—Epirubicin—stomach cancer	3.29e-05	0.000537	CcSEcCtD
Nelarabine—DGUOK—Metabolism—TYMS—stomach cancer	3.29e-05	0.000611	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1B—stomach cancer	3.28e-05	0.000609	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTM1—stomach cancer	3.25e-05	0.000604	CbGpPWpGaD
Nelarabine—Chest pain—Methotrexate—stomach cancer	3.24e-05	0.000528	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—stomach cancer	3.24e-05	0.000528	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—stomach cancer	3.24e-05	0.000528	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—stomach cancer	3.23e-05	0.000526	CcSEcCtD
Nelarabine—Leukopenia—Epirubicin—stomach cancer	3.19e-05	0.00052	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—stomach cancer	3.19e-05	0.00052	CcSEcCtD
Nelarabine—ADA—Metabolism—PLIN2—stomach cancer	3.19e-05	0.000592	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—NPM1—stomach cancer	3.17e-05	0.000589	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1A—stomach cancer	3.14e-05	0.000583	CbGpPWpGaD
Nelarabine—Confusional state—Methotrexate—stomach cancer	3.13e-05	0.000511	CcSEcCtD
Nelarabine—Loss of consciousness—Epirubicin—stomach cancer	3.13e-05	0.00051	CcSEcCtD
Nelarabine—DCK—Metabolism—CKB—stomach cancer	3.13e-05	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NDUFA2—stomach cancer	3.13e-05	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA1—stomach cancer	3.13e-05	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FBP1—stomach cancer	3.13e-05	0.000581	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—stomach cancer	3.12e-05	0.000579	CbGpPWpGaD
Nelarabine—Cough—Epirubicin—stomach cancer	3.11e-05	0.000507	CcSEcCtD
Nelarabine—Vision blurred—Doxorubicin—stomach cancer	3.11e-05	0.000506	CcSEcCtD
Nelarabine—ADA—Metabolism—CA2—stomach cancer	3.1e-05	0.000576	CbGpPWpGaD
Nelarabine—Asthenia—Docetaxel—stomach cancer	3.09e-05	0.000504	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	3.09e-05	0.000574	CbGpPWpGaD
Nelarabine—Convulsion—Epirubicin—stomach cancer	3.09e-05	0.000503	CcSEcCtD
Nelarabine—Infection—Methotrexate—stomach cancer	3.09e-05	0.000503	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ERCC2—stomach cancer	3.06e-05	0.000568	CbGpPWpGaD
Nelarabine—Nervous system disorder—Methotrexate—stomach cancer	3.05e-05	0.000497	CcSEcCtD
Nelarabine—Anaemia—Doxorubicin—stomach cancer	3.05e-05	0.000497	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—stomach cancer	3.04e-05	0.000496	CcSEcCtD
Nelarabine—Myalgia—Epirubicin—stomach cancer	3.03e-05	0.000494	CcSEcCtD
Nelarabine—Arthralgia—Epirubicin—stomach cancer	3.03e-05	0.000494	CcSEcCtD
Nelarabine—Chest pain—Epirubicin—stomach cancer	3.03e-05	0.000494	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—CDKN1A—stomach cancer	3.03e-05	0.000562	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NT5E—stomach cancer	3.02e-05	0.000561	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PGAM1—stomach cancer	3.02e-05	0.000561	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	3e-05	0.000558	CbGpPWpGaD
Nelarabine—Asthenia—Capecitabine—stomach cancer	3e-05	0.000488	CcSEcCtD
Nelarabine—POLA1—S Phase—CDKN1B—stomach cancer	2.98e-05	0.000553	CbGpPWpGaD
Nelarabine—Anorexia—Methotrexate—stomach cancer	2.96e-05	0.000483	CcSEcCtD
Nelarabine—Leukopenia—Doxorubicin—stomach cancer	2.95e-05	0.000481	CcSEcCtD
Nelarabine—Diarrhoea—Docetaxel—stomach cancer	2.95e-05	0.000481	CcSEcCtD
Nelarabine—DCK—Metabolism—PLIN2—stomach cancer	2.94e-05	0.000546	CbGpPWpGaD
Nelarabine—Confusional state—Epirubicin—stomach cancer	2.93e-05	0.000478	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	2.91e-05	0.00054	CbGpPWpGaD
Nelarabine—Oedema—Epirubicin—stomach cancer	2.91e-05	0.000474	CcSEcCtD
Nelarabine—Hypotension—Methotrexate—stomach cancer	2.9e-05	0.000473	CcSEcCtD
Nelarabine—Loss of consciousness—Doxorubicin—stomach cancer	2.9e-05	0.000472	CcSEcCtD
Nelarabine—Infection—Epirubicin—stomach cancer	2.89e-05	0.000471	CcSEcCtD
Nelarabine—ADA—Metabolism—PLCE1—stomach cancer	2.88e-05	0.000535	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALDH7A1—stomach cancer	2.88e-05	0.000535	CbGpPWpGaD
Nelarabine—Cough—Doxorubicin—stomach cancer	2.88e-05	0.000469	CcSEcCtD
Nelarabine—DGUOK—Metabolism—MTHFR—stomach cancer	2.87e-05	0.000533	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA2—stomach cancer	2.86e-05	0.000531	CbGpPWpGaD
Nelarabine—Convulsion—Doxorubicin—stomach cancer	2.86e-05	0.000465	CcSEcCtD
Nelarabine—Diarrhoea—Capecitabine—stomach cancer	2.86e-05	0.000465	CcSEcCtD
Nelarabine—Nervous system disorder—Epirubicin—stomach cancer	2.85e-05	0.000465	CcSEcCtD
Nelarabine—Dizziness—Docetaxel—stomach cancer	2.85e-05	0.000465	CcSEcCtD
Nelarabine—Thrombocytopenia—Epirubicin—stomach cancer	2.85e-05	0.000464	CcSEcCtD
Nelarabine—POLA1—S Phase—CCND1—stomach cancer	2.84e-05	0.000527	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUN—stomach cancer	2.83e-05	0.000526	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Methotrexate—stomach cancer	2.83e-05	0.000461	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PPP2R1A—stomach cancer	2.81e-05	0.000523	CbGpPWpGaD
Nelarabine—Insomnia—Methotrexate—stomach cancer	2.81e-05	0.000458	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—stomach cancer	2.81e-05	0.000457	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—stomach cancer	2.81e-05	0.000457	CcSEcCtD
Nelarabine—Chest pain—Doxorubicin—stomach cancer	2.81e-05	0.000457	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—stomach cancer	2.79e-05	0.000455	CcSEcCtD
Nelarabine—DCK—Metabolism—NT5E—stomach cancer	2.79e-05	0.000518	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PGAM1—stomach cancer	2.79e-05	0.000518	CbGpPWpGaD
Nelarabine—Anorexia—Epirubicin—stomach cancer	2.77e-05	0.000452	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—stomach cancer	2.77e-05	0.000451	CcSEcCtD
Nelarabine—ADA—Metabolism—UMPS—stomach cancer	2.76e-05	0.000513	CbGpPWpGaD
Nelarabine—Somnolence—Methotrexate—stomach cancer	2.76e-05	0.00045	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—stomach cancer	2.76e-05	0.000513	CbGpPWpGaD
Nelarabine—Dizziness—Capecitabine—stomach cancer	2.76e-05	0.00045	CcSEcCtD
Nelarabine—POLA1—S Phase—CDKN1A—stomach cancer	2.75e-05	0.00051	CbGpPWpGaD
Nelarabine—Vomiting—Docetaxel—stomach cancer	2.74e-05	0.000447	CcSEcCtD
Nelarabine—Hypotension—Epirubicin—stomach cancer	2.72e-05	0.000443	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—stomach cancer	2.71e-05	0.000442	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	2.71e-05	0.000503	CbGpPWpGaD
Nelarabine—Decreased appetite—Methotrexate—stomach cancer	2.7e-05	0.00044	CcSEcCtD
Nelarabine—Headache—Docetaxel—stomach cancer	2.7e-05	0.00044	CcSEcCtD
Nelarabine—Oedema—Doxorubicin—stomach cancer	2.69e-05	0.000438	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—stomach cancer	2.68e-05	0.000437	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—stomach cancer	2.68e-05	0.000437	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—MAPK8—stomach cancer	2.68e-05	0.000497	CbGpPWpGaD
Nelarabine—Infection—Doxorubicin—stomach cancer	2.67e-05	0.000436	CcSEcCtD
Nelarabine—DCK—Metabolism—ALDH7A1—stomach cancer	2.66e-05	0.000494	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLCE1—stomach cancer	2.66e-05	0.000494	CbGpPWpGaD
Nelarabine—Pain—Methotrexate—stomach cancer	2.66e-05	0.000433	CcSEcCtD
Nelarabine—Vomiting—Capecitabine—stomach cancer	2.65e-05	0.000432	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CAV1—stomach cancer	2.65e-05	0.000492	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Epirubicin—stomach cancer	2.65e-05	0.000432	CcSEcCtD
Nelarabine—DGUOK—Metabolism—APOA1—stomach cancer	2.64e-05	0.000491	CbGpPWpGaD
Nelarabine—Nervous system disorder—Doxorubicin—stomach cancer	2.64e-05	0.00043	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—stomach cancer	2.64e-05	0.000489	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Doxorubicin—stomach cancer	2.64e-05	0.000429	CcSEcCtD
Nelarabine—Insomnia—Epirubicin—stomach cancer	2.63e-05	0.000429	CcSEcCtD
Nelarabine—Headache—Capecitabine—stomach cancer	2.62e-05	0.000426	CcSEcCtD
Nelarabine—Paraesthesia—Epirubicin—stomach cancer	2.61e-05	0.000425	CcSEcCtD
Nelarabine—Dyspnoea—Epirubicin—stomach cancer	2.59e-05	0.000422	CcSEcCtD
Nelarabine—Somnolence—Epirubicin—stomach cancer	2.59e-05	0.000421	CcSEcCtD
Nelarabine—ADA—Metabolism—PDHA1—stomach cancer	2.57e-05	0.000477	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ECHS1—stomach cancer	2.57e-05	0.000477	CbGpPWpGaD
Nelarabine—Anorexia—Doxorubicin—stomach cancer	2.57e-05	0.000418	CcSEcCtD
Nelarabine—Nausea—Docetaxel—stomach cancer	2.56e-05	0.000417	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—stomach cancer	2.56e-05	0.000417	CcSEcCtD
Nelarabine—DCK—Metabolism—UMPS—stomach cancer	2.55e-05	0.000474	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—stomach cancer	2.55e-05	0.000473	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Methotrexate—stomach cancer	2.54e-05	0.000414	CcSEcCtD
Nelarabine—Decreased appetite—Epirubicin—stomach cancer	2.53e-05	0.000412	CcSEcCtD
Nelarabine—Hypotension—Doxorubicin—stomach cancer	2.52e-05	0.00041	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Epirubicin—stomach cancer	2.51e-05	0.000409	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—MYC—stomach cancer	2.51e-05	0.000466	CbGpPWpGaD
Nelarabine—Fatigue—Epirubicin—stomach cancer	2.51e-05	0.000409	CcSEcCtD
Nelarabine—Pain—Epirubicin—stomach cancer	2.49e-05	0.000405	CcSEcCtD
Nelarabine—Constipation—Epirubicin—stomach cancer	2.49e-05	0.000405	CcSEcCtD
Nelarabine—Nausea—Capecitabine—stomach cancer	2.48e-05	0.000404	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	2.47e-05	0.000458	CbGpPWpGaD
Nelarabine—Abdominal pain—Methotrexate—stomach cancer	2.46e-05	0.0004	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—stomach cancer	2.46e-05	0.0004	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	2.45e-05	0.000399	CcSEcCtD
Nelarabine—Insomnia—Doxorubicin—stomach cancer	2.43e-05	0.000397	CcSEcCtD
Nelarabine—Paraesthesia—Doxorubicin—stomach cancer	2.42e-05	0.000394	CcSEcCtD
Nelarabine—ADA—Metabolism—TYMP—stomach cancer	2.42e-05	0.000449	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FADS1—stomach cancer	2.42e-05	0.000449	CbGpPWpGaD
Nelarabine—Dyspnoea—Doxorubicin—stomach cancer	2.4e-05	0.000391	CcSEcCtD
Nelarabine—Feeling abnormal—Epirubicin—stomach cancer	2.4e-05	0.00039	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—stomach cancer	2.39e-05	0.00039	CcSEcCtD
Nelarabine—Gastrointestinal pain—Epirubicin—stomach cancer	2.38e-05	0.000387	CcSEcCtD
Nelarabine—DCK—Metabolism—PDHA1—stomach cancer	2.37e-05	0.00044	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ECHS1—stomach cancer	2.37e-05	0.00044	CbGpPWpGaD
Nelarabine—Decreased appetite—Doxorubicin—stomach cancer	2.34e-05	0.000381	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PPARG—stomach cancer	2.33e-05	0.000433	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Doxorubicin—stomach cancer	2.32e-05	0.000379	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—stomach cancer	2.32e-05	0.000378	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—APEX1—stomach cancer	2.31e-05	0.000429	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—stomach cancer	2.31e-05	0.000429	CbGpPWpGaD
Nelarabine—Pain—Doxorubicin—stomach cancer	2.3e-05	0.000375	CcSEcCtD
Nelarabine—Constipation—Doxorubicin—stomach cancer	2.3e-05	0.000375	CcSEcCtD
Nelarabine—Abdominal pain—Epirubicin—stomach cancer	2.3e-05	0.000375	CcSEcCtD
Nelarabine—Body temperature increased—Epirubicin—stomach cancer	2.3e-05	0.000375	CcSEcCtD
Nelarabine—POLA1—S Phase—MYC—stomach cancer	2.28e-05	0.000423	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SREBF2—stomach cancer	2.26e-05	0.00042	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.26e-05	0.00042	CbGpPWpGaD
Nelarabine—ADA—Metabolism—RORA—stomach cancer	2.24e-05	0.000415	CbGpPWpGaD
Nelarabine—Asthenia—Methotrexate—stomach cancer	2.23e-05	0.000363	CcSEcCtD
Nelarabine—DCK—Metabolism—TYMP—stomach cancer	2.23e-05	0.000414	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FADS1—stomach cancer	2.23e-05	0.000414	CbGpPWpGaD
Nelarabine—Feeling abnormal—Doxorubicin—stomach cancer	2.22e-05	0.000361	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.21e-05	0.00041	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Doxorubicin—stomach cancer	2.2e-05	0.000359	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CHEK2—stomach cancer	2.13e-05	0.000395	CbGpPWpGaD
Nelarabine—Abdominal pain—Doxorubicin—stomach cancer	2.13e-05	0.000347	CcSEcCtD
Nelarabine—Body temperature increased—Doxorubicin—stomach cancer	2.13e-05	0.000347	CcSEcCtD
Nelarabine—Diarrhoea—Methotrexate—stomach cancer	2.13e-05	0.000346	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—stomach cancer	2.11e-05	0.000393	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	2.11e-05	0.000391	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALB—stomach cancer	2.1e-05	0.000389	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALDOB—stomach cancer	2.1e-05	0.000389	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.09e-05	0.000389	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SREBF2—stomach cancer	2.09e-05	0.000388	CbGpPWpGaD
Nelarabine—Asthenia—Epirubicin—stomach cancer	2.09e-05	0.00034	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—APEX1—stomach cancer	2.07e-05	0.000384	CbGpPWpGaD
Nelarabine—DCK—Metabolism—RORA—stomach cancer	2.06e-05	0.000383	CbGpPWpGaD
Nelarabine—Dizziness—Methotrexate—stomach cancer	2.06e-05	0.000335	CcSEcCtD
Nelarabine—DGUOK—Metabolism—NOS3—stomach cancer	2e-05	0.000372	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2e-05	0.000371	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.99e-05	0.00037	CbGpPWpGaD
Nelarabine—Diarrhoea—Epirubicin—stomach cancer	1.99e-05	0.000324	CcSEcCtD
Nelarabine—Vomiting—Methotrexate—stomach cancer	1.98e-05	0.000322	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PRKCB—stomach cancer	1.97e-05	0.000366	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALOX5—stomach cancer	1.95e-05	0.000362	CbGpPWpGaD
Nelarabine—Headache—Methotrexate—stomach cancer	1.95e-05	0.000317	CcSEcCtD
Nelarabine—DCK—Metabolism—ALDOB—stomach cancer	1.93e-05	0.000359	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.93e-05	0.000359	CbGpPWpGaD
Nelarabine—Asthenia—Doxorubicin—stomach cancer	1.93e-05	0.000315	CcSEcCtD
Nelarabine—Dizziness—Epirubicin—stomach cancer	1.92e-05	0.000313	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—TYMS—stomach cancer	1.92e-05	0.000356	CbGpPWpGaD
Nelarabine—ADA—Metabolism—DPYD—stomach cancer	1.92e-05	0.000356	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.89e-05	0.00035	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PPP2R1A—stomach cancer	1.88e-05	0.000349	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—stomach cancer	1.87e-05	0.000347	CbGpPWpGaD
Nelarabine—Vomiting—Epirubicin—stomach cancer	1.85e-05	0.000301	CcSEcCtD
Nelarabine—Nausea—Methotrexate—stomach cancer	1.85e-05	0.000301	CcSEcCtD
Nelarabine—Diarrhoea—Doxorubicin—stomach cancer	1.84e-05	0.0003	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—stomach cancer	1.83e-05	0.00034	CbGpPWpGaD
Nelarabine—Headache—Epirubicin—stomach cancer	1.82e-05	0.000297	CcSEcCtD
Nelarabine—DCK—Metabolism—ALOX5—stomach cancer	1.8e-05	0.000334	CbGpPWpGaD
Nelarabine—Dizziness—Doxorubicin—stomach cancer	1.78e-05	0.00029	CcSEcCtD
Nelarabine—DCK—Metabolism—DPYD—stomach cancer	1.77e-05	0.000328	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.74e-05	0.000323	CbGpPWpGaD
Nelarabine—Nausea—Epirubicin—stomach cancer	1.73e-05	0.000281	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—stomach cancer	1.73e-05	0.000321	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TYMS—stomach cancer	1.72e-05	0.000319	CbGpPWpGaD
Nelarabine—Vomiting—Doxorubicin—stomach cancer	1.71e-05	0.000279	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—IL6—stomach cancer	1.71e-05	0.000318	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTT1—stomach cancer	1.69e-05	0.000315	CbGpPWpGaD
Nelarabine—Headache—Doxorubicin—stomach cancer	1.69e-05	0.000275	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP2A6—stomach cancer	1.67e-05	0.000311	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.65e-05	0.000306	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKR1C3—stomach cancer	1.63e-05	0.000302	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.6e-05	0.000297	CbGpPWpGaD
Nelarabine—Nausea—Doxorubicin—stomach cancer	1.6e-05	0.00026	CcSEcCtD
Nelarabine—ADA—Metabolism—ENO1—stomach cancer	1.59e-05	0.000295	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.57e-05	0.000291	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.57e-05	0.000291	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—stomach cancer	1.56e-05	0.00029	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2A6—stomach cancer	1.55e-05	0.000287	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BIRC5—stomach cancer	1.54e-05	0.000287	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKR1C3—stomach cancer	1.5e-05	0.000279	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK4—stomach cancer	1.5e-05	0.000278	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.49e-05	0.000277	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.48e-05	0.000275	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PRKCB—stomach cancer	1.47e-05	0.000273	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENO1—stomach cancer	1.47e-05	0.000272	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CD44—stomach cancer	1.41e-05	0.000261	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.36e-05	0.000252	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDK4—stomach cancer	1.34e-05	0.000249	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PRKCB—stomach cancer	1.32e-05	0.000244	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.32e-05	0.000244	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CD44—stomach cancer	1.3e-05	0.000241	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPP2R1A—stomach cancer	1.2e-05	0.000222	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTP1—stomach cancer	1.17e-05	0.000218	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMOX1—stomach cancer	1.16e-05	0.000215	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—stomach cancer	1.14e-05	0.000212	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CA—stomach cancer	1.13e-05	0.000209	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPP2R1A—stomach cancer	1.11e-05	0.000205	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TYMS—stomach cancer	1.09e-05	0.000203	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTP1—stomach cancer	1.08e-05	0.000201	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—stomach cancer	1.08e-05	0.0002	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMOX1—stomach cancer	1.07e-05	0.000198	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—stomach cancer	1.07e-05	0.000198	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—stomach cancer	1.02e-05	0.00019	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ERCC2—stomach cancer	1.01e-05	0.000188	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—stomach cancer	1.01e-05	0.000188	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—stomach cancer	1.01e-05	0.000188	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TYMS—stomach cancer	1.01e-05	0.000187	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—stomach cancer	9.96e-06	0.000185	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—stomach cancer	9.67e-06	0.000179	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTHFR—stomach cancer	9.54e-06	0.000177	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ERCC2—stomach cancer	9.37e-06	0.000174	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—stomach cancer	9.35e-06	0.000174	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1B—stomach cancer	9.06e-06	0.000168	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—stomach cancer	8.8e-06	0.000163	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAV1—stomach cancer	8.8e-06	0.000163	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA1—stomach cancer	8.78e-06	0.000163	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND1—stomach cancer	8.64e-06	0.00016	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1A—stomach cancer	8.36e-06	0.000155	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAV1—stomach cancer	8.12e-06	0.000151	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOA1—stomach cancer	8.1e-06	0.00015	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—stomach cancer	7.97e-06	0.000148	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—stomach cancer	7.75e-06	0.000144	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—stomach cancer	7.73e-06	0.000144	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK1—stomach cancer	7.59e-06	0.000141	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—stomach cancer	7.14e-06	0.000133	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK3—stomach cancer	7.13e-06	0.000132	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—stomach cancer	6.96e-06	0.000129	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—stomach cancer	6.93e-06	0.000129	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK1—stomach cancer	6.78e-06	0.000126	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NOS3—stomach cancer	6.65e-06	0.000124	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—stomach cancer	6.42e-06	0.000119	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NOS3—stomach cancer	6.14e-06	0.000114	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—stomach cancer	6.08e-06	0.000113	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—stomach cancer	5.69e-06	0.000106	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—stomach cancer	5.62e-06	0.000104	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—stomach cancer	3.74e-06	6.95e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—stomach cancer	3.45e-06	6.41e-05	CbGpPWpGaD
